Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.

Keil S, Matter H, Schönafinger K, Glien M, Mathieu M, Marquette JP, Michot N, Haag-Diergarten S, Urmann M, Wendler W.

ChemMedChem. 2011 Apr 4;6(4):633-53. doi: 10.1002/cmdc.201100047. Epub 2011 Mar 11.

PMID:
21400663
2.

Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.

Schindler U, Strobel H, Schönafinger K, Linz W, Löhn M, Martorana PA, Rütten H, Schindler PW, Busch AE, Sohn M, Töpfer A, Pistorius A, Jannek C, Mülsch A.

Mol Pharmacol. 2006 Apr;69(4):1260-8. Epub 2005 Dec 6.

PMID:
16332991
3.

Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.

Klabunde T, Wendt KU, Kadereit D, Brachvogel V, Burger HJ, Herling AW, Oikonomakos NG, Kosmopoulou MN, Schmoll D, Sarubbi E, von Roedern E, Schönafinger K, Defossa E.

J Med Chem. 2005 Oct 6;48(20):6178-93.

PMID:
16190745
4.

Heterocyclic NO prodrugs.

Schönafinger K.

Farmaco. 1999 May 30;54(5):316-20. Review.

PMID:
10418124
5.

Characterisation of furoxancarbonitriles as a new class of vasodilators.

Gasco AM, Boschi D, Di Stilo A, Medana C, Gasco A, Martorana PA, Schönafinger K.

Arzneimittelforschung. 1998 Mar;48(3):212-8.

PMID:
9553676
6.

Cardiovascular actions of the furoxan CAS 1609, a novel nitric oxide donor.

Bohn H, Brendel J, Martorana PA, Schönafinger K.

Br J Pharmacol. 1995 Apr;114(8):1605-12.

7.

Antiischemic effects of pirsidomine, a new nitric oxide donor.

Martorana PA, Kettenbach B, Bohn H, Schönafinger K, Henning R.

Eur J Pharmacol. 1994 May 23;257(3):267-73.

PMID:
8088346
8.

Thiol-mediated generation of nitric oxide accounts for the vasodilator action of furoxans.

Feelisch M, Schönafinger K, Noack E.

Biochem Pharmacol. 1992 Sep 25;44(6):1149-57.

PMID:
1358072
9.
10.

CAS 936, a novel syndnonimine with direct vasodilating and nitric oxide-donating properties: effects on isolated blood vessels.

Bohn H, Beyerle R, Martorana PA, Schönafinger K.

J Cardiovasc Pharmacol. 1991 Oct;18(4):522-7.

PMID:
1724528
11.

[Nitric oxide dependence of the anti-thrombotic effect of sydnonimines in coronary arteries of swine].

Just M, Schönafinger K, Martorana PA.

Z Kardiol. 1991;80 Suppl 5:29-33. German.

PMID:
1776332
12.

Oxygen and oxidation promote the release of nitric oxide from sydnonimines.

Bohn H, Schönafinger K.

J Cardiovasc Pharmacol. 1989;14 Suppl 11:S6-12.

PMID:
2484701
13.

[New cardiovascular acting 2-aryl-2-imidazolinyl-acetic acids. Synthesis and pharmacologic effects].

Beyerle R, Bohn H, Schönafinger K, Martorana PA, Bender H.

Arzneimittelforschung. 1985;35(1):93-102. German.

PMID:
2859025

Supplemental Content

Loading ...
Support Center